Clinical Trial Detail

NCT ID NCT03821246
Title Neoadjuvant Atezolizumab With or Without Enzalutamide in Localized Prostate Cancer Given Before Radical Prostatectomy
Recruitment Recruiting
Gender male
Phase Phase II
Variant Requirements No
Sponsors University of California, San Francisco
Indications

prostate adenocarcinoma

Therapies

Atezolizumab + Emactuzumab

Atezolizumab

Atezolizumab + Enzalutamide

Age Groups: adult senior

No variant requirements are available.